- Home
- TWST
as 02-05-2025 9:43am EST
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 3.1B | IPO Year: | 2018 |
| Target Price: | $52.50 | AVG Volume (30 days): | 773.9K |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.38 | EPS Growth: | N/A |
| 52 Week Low/High: | $27.41 - $60.90 | Next Earning Date: | 02-03-2025 |
| Revenue: | $330,189,000 | Revenue Growth: | 25.85% |
| Revenue Growth (this year): | 21.65% | Revenue Growth (next year): | 17.56% |
Stock Insider Trading Activity of Twist Bioscience Corporation (TWST)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Laponis Adam | TWST | Chief Financial Officer | Jan 10 '25 | Sell | $43.26 | 5,886 | $254,646.02 | 110,096 | |
| CHESS ROBERT | TWST | Director | Jan 7 '25 | Sell | $50.00 | 5,000 | $250,000.00 | 16,641 | |
| Green Paula | TWST | SVP of Human Resources | Jan 3 '25 | Sell | $45.59 | 160 | $7,294.58 | 133,273 | |
| Cho Dennis | TWST | See Remarks | Jan 3 '25 | Sell | $45.59 | 144 | $6,565.12 | 113,027 | |
| Finn Patrick John | TWST | President and COO | Jan 3 '25 | Sell | $45.59 | 229 | $10,440.36 | 274,466 | |
| Leproust Emily M. | TWST | Chief Executive Officer | Dec 20 '24 | Sell | $44.90 | 1,654 | $74,269.56 | 673,064 | |
| Green Paula | TWST | SVP of Human Resources | Dec 20 '24 | Sell | $44.90 | 282 | $12,662.65 | 133,273 | |
| Cho Dennis | TWST | See Remarks | Dec 20 '24 | Sell | $44.90 | 316 | $14,189.35 | 113,027 | |
| Cho Dennis | TWST | See Remarks | Dec 16 '24 | Sell | $46.81 | 133 | $6,225.33 | 113,027 | |
| Leproust Emily M. | TWST | Chief Executive Officer | Dec 6 '24 | Sell | $52.70 | 2,216 | $116,792.06 | 673,064 |
Latest Twist Bioscience Corporation News
TWST Breaking Stock News: Dive into TWST Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Company News for Feb 4, 2025
GuruFocus.com
a day ago
Twist Bioscience Corp (TWST) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...
Thomson Reuters StreetEvents
a day ago
Q1 2025 Twist Bioscience Corp Earnings Call
Zacks
2 days ago
Twist Bioscience (TWST) Reports Q1 Loss, Tops Revenue Estimates
MT Newswires
2 days ago
Twist Bioscience's Fiscal Q1 Loss Narrows, Revenue Rises; Fiscal 2025 Sales Guidance Lifted
Associated Press Finance
2 days ago
Twist Bioscience: Fiscal Q1 Earnings Snapshot
Business Wire
2 days ago
Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results
GuruFocus.com
5 days ago
Twist Bioscience Corp (TWST) Q1 2025 Earnings Report Preview: What to Look For
Compare TWST vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TWST Twist Bioscience Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.